Scalable synthetic microsphere platform that mimics natural antigen-presenting cells to activate and expand T cells with improved quality and consistency

Applications: T-cell therapy manufacturing, immunotherapy, research tools

Features	Benefits
Tuneable synthetic microspheres	Higher-quality T-cell products
Controlled T-cell activation	Better phenotype (e.g. killing properties and longevity)
Scalable and reproducible process	Manufacturing consistency
Applicable to other cell types	Broad adaptability across therapies

Patent pending (PCT/EP2026/050665), available for :

Request more information
about this technology

Technologies for License